339 related articles for article (PubMed ID: 33156626)
1. Electron-Accepting Micelles Deplete Reduced Nicotinamide Adenine Dinucleotide Phosphate and Impair Two Antioxidant Cascades for Ferroptosis-Induced Tumor Eradication.
Guo X; Liu F; Deng J; Dai P; Qin Y; Li Z; Wang B; Fan A; Wang Z; Zhao Y
ACS Nano; 2020 Nov; 14(11):14715-14730. PubMed ID: 33156626
[TBL] [Abstract][Full Text] [Related]
2. Triggered ferroptotic polymer micelles for reversing multidrug resistance to chemotherapy.
Gao M; Deng J; Liu F; Fan A; Wang Y; Wu H; Ding D; Kong D; Wang Z; Peer D; Zhao Y
Biomaterials; 2019 Dec; 223():119486. PubMed ID: 31520887
[TBL] [Abstract][Full Text] [Related]
3. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation.
An Y; Zhu J; Liu F; Deng J; Meng X; Liu G; Wu H; Fan A; Wang Z; Zhao Y
ACS Appl Mater Interfaces; 2019 Aug; 11(33):29655-29666. PubMed ID: 31359759
[TBL] [Abstract][Full Text] [Related]
4. Drug-independent NADPH-consuming micelles collaborate with ROS-generator for cascade ferroptosis amplification by impairing redox homeostasis.
Yu F; Shang X; Wang Z; Zhu Y; Chen S; Yuan H; Hu F
Mater Today Bio; 2023 Feb; 18():100532. PubMed ID: 36691607
[TBL] [Abstract][Full Text] [Related]
5. Triggered All-Active Metal Organic Framework: Ferroptosis Machinery Contributes to the Apoptotic Photodynamic Antitumor Therapy.
Meng X; Deng J; Liu F; Guo T; Liu M; Dai P; Fan A; Wang Z; Zhao Y
Nano Lett; 2019 Nov; 19(11):7866-7876. PubMed ID: 31594301
[TBL] [Abstract][Full Text] [Related]
6. Coenzyme-depleting nanocarriers for enhanced redox cancer therapy under hypoxia.
Li Y; Liu M; Zheng Y; Wang Z; Zhao Y
J Colloid Interface Sci; 2023 Jul; 641():135-145. PubMed ID: 36931212
[TBL] [Abstract][Full Text] [Related]
7. Effect of Malt-PEG-Abz@RSL3 micelles on HepG2 cells based on NADPH depletion and GPX4 inhibition in ferroptosis.
Li W; Liu X; Cheng X; Zhang W; Gong C; Gao C; Peng H; Yang B; Tang S; Tao H
J Drug Target; 2022 Feb; 30(2):208-218. PubMed ID: 34236257
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-responsive nanocarriers for chemotherapy sensitization via dual-mode inhibition of hypoxia-inducible factor-1 alpha.
Wang Z; Mu X; Yang Q; Luo J; Zhao Y
J Colloid Interface Sci; 2022 Dec; 628(Pt B):106-115. PubMed ID: 35987150
[TBL] [Abstract][Full Text] [Related]
9. Application of singlet oxygen-activatable nanocarriers to boost X-ray-induced photodynamic therapy and cascaded ferroptosis for breast cancer treatment.
Zhang B; Liu H; Wang Y; Zhang Y; Cheng J
J Mater Chem B; 2023 Oct; 11(40):9685-9696. PubMed ID: 37789698
[TBL] [Abstract][Full Text] [Related]
10. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
[TBL] [Abstract][Full Text] [Related]
11. Acid-Responsive Micelles Releasing Cinnamaldehyde Enhance RSL3-Induced Ferroptosis in Tumor Cells.
Yan Z; Wu S; Zhou Y; Li F
ACS Biomater Sci Eng; 2022 Jun; 8(6):2508-2517. PubMed ID: 35648631
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia responsive nano-drug delivery system based on angelica polysaccharide for liver cancer therapy.
Liu X; Wu Z; Guo C; Guo H; Su Y; Chen Q; Sun C; Liu Q; Chen D; Mu H
Drug Deliv; 2022 Dec; 29(1):138-148. PubMed ID: 34967268
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
14. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
15. Nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy based on NADPH depletion.
Zhang C; Liu Z; Wang F; Zhang B; Zhang X; Guo P; Li T; Tai S; Zhang C
Drug Deliv; 2023 Dec; 30(1):2162160. PubMed ID: 36579634
[TBL] [Abstract][Full Text] [Related]
16. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
[TBL] [Abstract][Full Text] [Related]
17. An ROS-Activatable Nanoassembly Remodulates Tumor Cell Metabolism for Enhanced Ferroptosis Therapy.
Zhang Y; Li L; Li Y; Fei Y; Xue C; Yao X; Zhao Y; Wang X; Li M; Luo Z
Adv Healthc Mater; 2022 Jan; 11(2):e2101702. PubMed ID: 34710950
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia- and singlet oxygen-responsive chemo-photodynamic Micelles featured with glutathione depletion and aldehyde production.
Deng J; Liu F; Wang L; An Y; Gao M; Wang Z; Zhao Y
Biomater Sci; 2018 Dec; 7(1):429-441. PubMed ID: 30500010
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
Xu Y; Li X; Cheng Y; Yang M; Wang R
FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
[TBL] [Abstract][Full Text] [Related]
20. Reversing Ferroptosis Resistance in Breast Cancer via Tailored Lipid and Iron Presentation.
Luo J; Li Y; Li Y; Chen X; Du P; Wang Z; Tian A; Zhao Y
ACS Nano; 2023 Dec; 17(24):25257-25268. PubMed ID: 38055669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
